Cargando…
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Mounting evidence suggests that neuroinflammation is not just a consequence but a vital contributor to the development and progression of Parkinson’s disease (PD). Microglia in particular, may contribute to the induction and modulation of inflammation in PD. Upon stimulation, microglia convert into...
Autores principales: | Liu, Cai-Yun, Wang, Xu, Liu, Chang, Zhang, Hong-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877505/ https://www.ncbi.nlm.nih.gov/pubmed/31803024 http://dx.doi.org/10.3389/fncel.2019.00514 |
Ejemplares similares
-
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease
por: Subramaniam, Sudhakar R., et al.
Publicado: (2017) -
Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018) -
Microglial pyroptosis: Therapeutic target in secondary brain injury following intracerebral hemorrhage
por: Gu, Lingui, et al.
Publicado: (2022) -
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
por: Janda, Elzbieta, et al.
Publicado: (2018) -
Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals
por: Li, Yun-Fei, et al.
Publicado: (2022)